Clin2
NCT07445581Possibly a fitNot yet recruiting

Herbal medicine for elderly heart attack patients with brain artery narrowing

Acute Coronary Syndrome Comorbid With Cerebral Atherosclerosis

Part of Brain & nervous system, Heart & circulation clinical trials.

This study tests a traditional Chinese herbal medicine, Tanhuo Decoction, in elderly patients who have had a recent heart attack and also have narrowed brain arteries. It aims to see if adding this herbal treatment to standard care helps improve their recovery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
480 people
Ages
60 years and older
Study type
Interventional

Who can take part

  • You are 60 years or older.
  • You had a heart attack recently and your condition is stable within 24 hours of treatment.
  • You have had a previous stroke or have narrowing of at least 50% in the arteries in your neck or brain.
  • You have symptoms that match a 'fire-heat' pattern in traditional Chinese medicine, which your doctor can assess.
  • You do not have severe heart, liver, kidney, or bleeding problems, and you are not allergic to the study medicines.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07041359Recruiting· Phase 4
Traditional Chinese medicine for elderly heart disease patients with ongoing symptoms

This trial tests whether traditional Chinese medicine can help elderly patients with coronary heart disease who still have chest pain or discomfort despite standard treatments. It focuses on those who cannot have or have not fully benefited from procedures like stents or bypass surgery.

Beijing, Beijing Municipality
NCT06857487Recruiting· Phase 1/Phase 2
Testing an herb formula to prevent early stroke worsening

This study tests a traditional Chinese herb formula called Qingre Huatan to see if it can stop stroke symptoms from getting worse in the first few days. It is for people who have had an ischemic stroke within the last 48 hours and are at high risk for early decline.

Beijing, Beijing Municipality
NCT07250035Recruiting· Phase 3
Chinese herb trial for brain bleed linked to amyloid angiopathy

This trial tests a traditional Chinese medicine called Jiedu Huayu to see if it helps people recover from a brain bleed caused by a condition where proteins build up in blood vessel walls (cerebral amyloid angiopathy). The goal is to improve outcomes without surgery.

Beijing
NCT06901570Not yet recruiting· Phase 4
Aromatic Wentong herbal medicine for coronary microvascular disease

This study tests a Chinese herbal medicine called Aromatic Wentong to see if it can improve blood flow to the heart muscle in people with coronary microvascular disease — a condition where the heart's smallest blood vessels don't work well, causing chest pain. The trial aims to find out if this treatment helps reduce symptoms and improve heart function.

Beijing, Chaoyang District
NCT05583773Recruiting· Phase 4
Herbal medicine for heart failure with lower pumping strength

This trial tests SHengXIaN-QuYu decoction (an herbal treatment) in people with symptomatic heart failure and reduced pumping function. It looks to see whether the herbal formula is safe and helpful for heart failure symptoms and heart function.

Beijing, Beijing Municipality
NCT06549582Not yet recruiting
Chinese herbal formula for stroke recovery and heart health

This trial tests a Chinese herbal prescription to see if it can help repair blood vessels and improve fat processing in people who had a stroke about a month ago. It may help with recovery and prevent further heart or brain issues.

Hear when a new Acute Coronary Syndrome Comorbid With Cerebral Atherosclerosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.